Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats

Life Sciences

Volumn 60, Issue 15, 1997, Pages 1223-1230

  Yen, Mao Hsiung ^a   Liu, Yu Chun ^a   Hong, Hong Jye ^a   Sheu, Joen Rong ^b   Wu, Chin Chen ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

lipopolysaccharide; nitric oxide synthase inhibitors; spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

AMINOGUANIDINE; CYCLIC GMP; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; HEREDITARY HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PRESSOR RESPONSE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; SURVIVAL TIME; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCHERICHIA COLI; GUANIDINES; HYPERTENSION; LIPOPOLYSACCHARIDES; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SURVIVAL RATE;

ANIMALIA; ESCHERICHIA COLI;

EID: 0030942043     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00066-0     Document Type: Article

References (22)

1. S. MONCADA, R.M.J. PALMER and E.A. HIGGS, Pharmacol. Rev. 43 109-142 (1991).
2. C. NATHAN, FASEB J. 6 3051-3064 (1992).
3. U. FOSTERMANN, A. MULSCH, E. BOHME and R. RUSSE, Circ. Res. 58 531-538 (1986).
4. V.M. BOLOTINA, S. NAJIBI, J.J. PALACINO, P.J. PAGANO and R.A. Cohen, Nature 368 850-853 (1994)
5. J.A. PANZA, A.A. QUYYUMI, J.E. BRUSH and S.E. EPSTEIN, N. Engl. J. Med. 323 22-27 (1990).
6. J.R. FOZARD and M.L. PART, Br. J. Pharmacol. 102 823-826 (1991).
7. J. LI and R.D. BUKOSKI, Circ. Res. 72 290-296 (1993).
8. L. LEE and R.C. WEBB, Hypertension 19 435-441 (1992).
9. P.J. LACOLLEY, S.J. LEWIS and M.J. BRODY, Eur. J. Pharmacol. 197 239-240 (1991).
10. R. SCHLEIFFER, F. PERNOT, B. VAN-OVERLOOP and A. GAIRARD, J. Hypertens. 9(Suppl. 6) S192-S193 (1991).
11. M.C. MOURLON-LE GRAND, J. BENESSIANO and B.I. LEVY, Am. J. Physiol. 263 H61-H67 (1992).
12. D.C. JUNQUERO, T. SCOTT-BURDEN, V.B. SCHINI and P.M. VANHOUTTE, Gen. Hypertens. 218 3-5 (1992).
13. J. XIAO J and P.K.T. PANG, Am. J. Physiol. 266 H272-H278 (1994).
14. C. THIEMERMANN, Adv. Pharmacol. 28 45-79 (1994).
15. M. HECKER, J.A. MITCHELL, H.J. HARRIS, M. KATSURA, C. THIEMERMANN and J.R. VANE, Biochem. Biophys. Res. Commun. 167 1037-1043 (1990).
16. C.C. WU, S.J. CHEN, C. SZABO, C. THIEMERMANN and J.R. VANE, Br. J. Pharmacol. 114 1666-1672 (1995).
17. C.C. WU, W.F. CHIOU and M.H. YEN, Eur. J. Pharmacol. 169 189-195 (1989).
18. O.H. LOWERY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
19. D.C. JUNQUERO, V.B. SCHINI, T. SCOTT-BURDEN and P.M. VANHOUTTE, Am. J. Hypertens. 6 602-610 (1993).
20. K. KOGA, T. SATA, H. NANRI, H. SANO, M. IKEDA and A. SHIGEMATSU, Life Sci. 57 2309-2316 (1995).
21. J.A. SCOTT, M. MACHOUN and D.G. MCCORMACK, J. Appl. Physiol. 80 271-277 (1996).
22. T.F. LUSCHER, L. RAIJ and P.M. VANHOUTTE, Hypertension 9 157-163 (1987).